SomaLogic (FRA:76X0) Total Long-Term Assets : €66.47 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SomaLogic Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. SomaLogic's Total Long-Term Assets for the quarter that ended in Sep. 2023 was €66.47 Mil.

SomaLogic Total Long-Term Assets Historical Data

The historical data trend for SomaLogic's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomaLogic Total Long-Term Assets Chart

SomaLogic Annual Data

Trend

Dec20

Dec21

Dec22

Total Long-Term Assets

8.48

12.88

62.00

SomaLogic Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Long-Term Assets	Get a 7-Day Free Trial								67.65	62.00	62.75	64.13	66.47

SomaLogic Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

SomaLogic Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of SomaLogic's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

SomaLogic (FRA:76X0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SomaLogic Inc (FRA:76X0) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2945 Wilderness Place, Boulder, CO, USA, 80301

Website

https://www.somalogic.com

SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

SomaLogic (FRA:76X0) Headlines

No Headlines